Viewing Study NCT06732232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-01-19 @ 5:32 PM
Study NCT ID: NCT06732232
Status: RECRUITING
Last Update Posted: 2024-12-13
First Post: 2024-11-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Sponsor: Shanghai Cell Therapy Group Co.,Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed View
None Refractory View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed/refractory multiple myeloma View
None CAR-T View
None CD19 View
None CD22 View
None BCMA View